Three women experienced neurological symptoms following injections of botulinum toxin administered at a medical spa in Colorado. The symptoms included numbness and tingling, muscle weakness, dysphonia, blurred vision, and neck stiffness. All three patients received injections within a day of each other and reported the symptoms on the day of their injections. Public health officials initiated an investigation after the initial patient reported adverse effects to Rocky Mountain Poison and Drug Safety. The investigation revealed the use of both FDA-approved and unapproved products at the spa, alongside issues such as inappropriate diluent use, multiple patient vial usage, inadequate temperature monitoring, and the use of past beyond-use date products.
A text survey of 52 patients revealed two additional cases of symptoms following injections. These patients experienced dysphonia, headache, blurred vision, shortness of breath, muscle weakness, and headache. All three groups of patients received injections from the same lot of the unapproved product. The medical spa was instructed to cease using unapproved products, and a formal complaint was submitted. Potential causes for the symptoms included unknown product concentration, contamination, improper preparation, and improper storage. The CDC and FDA have previously issued warnings regarding counterfeit or mishandled botulinum toxin products and issued warning letters to websites selling unapproved products.”} />